Home Newsfeeds Jefferies Maintains Hold on FedEx, Raises Price Target to $175

Jefferies Maintains Hold on FedEx, Raises Price Target to $175

Jefferies analyst Stephanie Moore maintains FedEx (NYSE:FDX) with a Hold and raises the price target from $170 to $175.

byBenzinga Newsdesk

December 22, 2022

1 minute read

Jefferies analyst Stephanie Moore maintains FedEx (NYSE:FDX) with a Hold and raises the price target from $170 to $175.

Analyst Ratings

Unveiling 5 Analyst Insights On Editas Medicine

By Benzinga Insights

June 18, 1:00 PM

Throughout the last three months, 5 analysts have evaluated Editas Medicine (NASDAQ:EDIT), offering a diverse set of opinions…

EDIT

BioNTech and DualityBio Receive FDA Fast Track Designation for Next-Generation Antibody-Drug Conjugate Candidate BNT325/DB-1305

By Benzinga Newsdesk

January 31, 7:47 AM

BioNTech SE (NASDAQ:BNTX, ", BioNTech", )))) and Duality Biologics (Suzhou) Co., Ltd. ("DualityBio") today announced that the U.S. Food and Drug Administration ("FDA") granted

BNTX

DMK Pharmaceuticals Announces Presentation Of Preclinical Results Comparing Effects Of DPI-125 On Opioid Withdrawal Behaviors Versus Standard Of Care For Opioid Use Disorder At SfN Neuroscience 2023

By Benzinga Newsdesk

November 13, 11:53 AM

DMK Pharmaceuticals Corporation (NASDAQ:DMK), a commercial stage neuro-biotech company primarily focused on developing and commercializing products for the treatment of opioid overdose and substance use disorders, today

DMK